1. Home
  2. STEM vs MGX Comparison

STEM vs MGX Comparison

Compare STEM & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEM
  • MGX
  • Stock Information
  • Founded
  • STEM 2009
  • MGX 2018
  • Country
  • STEM United States
  • MGX United States
  • Employees
  • STEM N/A
  • MGX N/A
  • Industry
  • STEM Computer Software: Prepackaged Software
  • MGX
  • Sector
  • STEM Technology
  • MGX
  • Exchange
  • STEM Nasdaq
  • MGX NYSE
  • Market Cap
  • STEM 75.7M
  • MGX 62.1M
  • IPO Year
  • STEM N/A
  • MGX 2024
  • Fundamental
  • Price
  • STEM $0.50
  • MGX $1.79
  • Analyst Decision
  • STEM Hold
  • MGX Strong Buy
  • Analyst Count
  • STEM 9
  • MGX 4
  • Target Price
  • STEM $1.17
  • MGX $13.00
  • AVG Volume (30 Days)
  • STEM 3.1M
  • MGX 297.2K
  • Earning Date
  • STEM 04-29-2025
  • MGX 05-13-2025
  • Dividend Yield
  • STEM N/A
  • MGX N/A
  • EPS Growth
  • STEM N/A
  • MGX N/A
  • EPS
  • STEM N/A
  • MGX N/A
  • Revenue
  • STEM $151,627,000.00
  • MGX $45,263,000.00
  • Revenue This Year
  • STEM $5.72
  • MGX N/A
  • Revenue Next Year
  • STEM $19.61
  • MGX $8.34
  • P/E Ratio
  • STEM N/A
  • MGX N/A
  • Revenue Growth
  • STEM N/A
  • MGX N/A
  • 52 Week Low
  • STEM $0.29
  • MGX $1.23
  • 52 Week High
  • STEM $1.68
  • MGX $6.90
  • Technical
  • Relative Strength Index (RSI)
  • STEM 49.18
  • MGX 57.74
  • Support Level
  • STEM $0.45
  • MGX $1.59
  • Resistance Level
  • STEM $0.50
  • MGX $1.83
  • Average True Range (ATR)
  • STEM 0.05
  • MGX 0.11
  • MACD
  • STEM -0.01
  • MGX 0.02
  • Stochastic Oscillator
  • STEM 53.36
  • MGX 87.66

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

Share on Social Networks: